Veracyte to Participate in Upcoming Investor Conferences

On May 15, 2024 Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, reported it will participate in the following investor conferences (Press release, Veracyte, MAY 15, 2024, View Source [SID1234643334]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

-Leerink Partners 2024 Healthcare Crossroads Conference – Austin, TX
Fireside Chat on May 29th at 12:20 p.m. Eastern Time
-William Blair 44th Annual Growth Stock Conference – Chicago, IL
Presentation on June 4th at 5:40 p.m. Eastern Time
Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at View Source A replay of the webcasts will be available following the conclusion of the live presentation broadcast.